Skip to main content

Saskatchewan Roughriders wide receiver Marcus Thigpen, centre, and Spencer Moore celebrate a touchdown against the Edmonton Eskimos during second half CFL action at Mosaic Stadium in Regina on Nov. 4, 2017.

Mark Taylor/The Canadian Press

Saskatchewan Roughriders running back Marcus Thigpen has been suspended two games for violating the CFL and CFL Players Association's joint drug policy.

The CFL said in a statement Monday that Thigpen tested positive for the steroid dehydrochloromethyltestosterone in a random in-competition test last November.

Under the policy, a suspended player cannot participate in regular season or post-season games. It is up to the team to determine whether that player can participate in other team activities, such as practices and meetings.

Story continues below advertisement

Thigpen will be eligible to take part in pre-season games

"We are disappointed in Marcus and that he has tested positive for a banned substance," Roughriders head coach and general manager Chris Jones said in a statement. "We have been in conversation with Marcus and the CFL for clarity and accept the leagues decision and corresponding two-game suspension. Our organization fully supports the CFL/CFLPA policy preventing the use of performance-enhancing drugs."

Thigpen is in his second stint with the Riders after the CFL club signed him to its practice roster in September. While not making a large impact over the regular season, he rushed for 169 years and a touchdown on 15 carries in the Riders' 31-20 win at Ottawa in the East Division semifinal.

Report an error
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter